Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: A population-based study, 2004-2007

Thorax

Volumn 68, Issue 6, 2013, Pages 551-564

  Walters, Sarah ^a   Maringe, Camille ^a   Coleman, Michel P ^a   Peake, Michael D ^b,c   Butler, John ^d   Young, Nicholas ^e   Bergström, Stefan ^f   Hanna, Louise ^g   Jakobsen, Erik ^h   Kölbeck, Karl ⁱ   Sundstrøm, Stein ^j   Engholm, Gerda ^k   Gavin, Anna ^l   Gjerstorff, Marianne L ^m   Hatcher, Juanita ⁿ   Johannesen, Tom Børge ^o   Linklater, Karen M ^p   McGahan, Colleen E ^q   Steward, John ^r   Tracey, Elizabeth ^s   Turner, Donna ^t   Richards, Michael A ^b   Rachet, Bernard ^a   more..

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b Portland House   (United Kingdom)

^c GLENFIELD HOSPITAL   (United Kingdom)

^d ROYAL MARSDEN HOSPITAL   (United Kingdom)

^e UNIVERSITY OF BRISTOL   (United Kingdom)

^f GÄVLE HOSPITAL   (Sweden)

^g Velindre NHS Trust   (United Kingdom)

^h ODENSE UNIVERSITY HOSPITAL   (Denmark)

ⁱ KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^j TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^k DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^l Northern Ireland Cancer Registry   (United Kingdom)

^m Danish Cancer Registry   (Denmark)

ⁿ ALBERTA HEALTH SERVICES   (Canada)

^o CANCER REGISTRY OF NORWAY   (Norway)

^p Thames Cancer Registry   (United Kingdom)

^q BRITISH COLUMBIA CANCER AGENCY   (Canada)

^r Wales Cancer Intelligence and Surveillance Unit   (United Kingdom)

^s CANCER INSTITUTE NSW   (Australia)

^t CANCERCARE MANITOBA   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AUSTRALIA; CANADA; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; DENMARK; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NORWAY; POPULATION RESEARCH; PRIORITY JOURNAL; REVIEW; SWEDEN; UNITED KINGDOM;

EID: 84877626314     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2012-202297     Document Type: Article

References (36)

1. World Cancer Report. Lyon, France: International Agency for Research on Cancer, 2008.
2. Janssen-Heijnen ML, Coebergh JW. The changing epidemiology of lung cancer in Europe. Lung Cancer 2003;41:245-58. (Pubitemid 36970181)
3. Sankaranarayanan R, Swaminathan R. Cancer survival in Africa, Asia, the Caribbean and Central America. Lyon: International Agency for Research on Cancer, 2011.
4. Coleman MP, Quaresma M, Berrino F, et al. Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol 2008;9:730-56.
5. Berrino F, De Angelis R, Sant M, et al. Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol 2007;8:773-83. (Pubitemid 47321600)
6. Department of Health. Improving outcomes: a strategy for cancer. London: Department of Health, 2011.
7. Abdel-Rahman M, Stockton D, Rachet B, et al. What if cancer survival in Britain were the same as in Europe: how many deaths are avoidable? Br J Cancer 2009;101(Suppl 2):115-24.
8. Coleman MP, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2011;377:127-38.
9. Ciccolallo L, Capocaccia R, Coleman MP, et al. Survival differences between European and US patients with colorectal cancer: role of stage at diagnosis and surgery. Gut 2005;54:268-73. (Pubitemid 40139245)
10. Sant M, Allemani C, Capocaccia R, et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 2003;106:416-22. (Pubitemid 36870406)
11. Woods LM, Rachet B, O'Connell D, et al. Large differences in patterns of breast cancer survival between Australia and England: a comparative study using cancer registry data. Int J Cancer 2009;124:2391-9.
12. Maringe C, Walters S, Butler J, et al. Stage at diagnosis and ovarian cancer survival: evidence from the International Cancer Benchmarking Partnership. Gynecol Oncol 2012;127:75-82.
13. Storm HH, Dickman PW, Engeland A, et al. Do morphology and stage explain the inferior lung cancer survival in Denmark? Eur Respir J 1999;13:430-5. (Pubitemid 29086845)
14. Sobin LH, Gospodarowicz M, Wittekind C. TNM classification of malignant tumours. 7th edn. Oxford: Union for International Cancer Control (UICC), Wiley-Blackwell, 2009.
15. Young JL, Roffers SD, Ries L A G, et al. SEER summary staging manual-2000: Codes and Coding Instructions. NIH Pub. No. 01-4969. Bethesda: National Cancer Institute, 2001.
16. Walters S, Maringe C, Butler J, et al. Comparability of stage data in cancer registries in six countries: lessons from the International Cancer Benchmarking Partnership. Int J Cancer 2013;132:676-85.
17. Lambert PC, Royston P. Further development of flexible parametric models for survival analysis. Stata J 2009;9:265-90.
18. Remontet L, Bossard N, Belot A, et al. An overall strategy based on regression models to estimate relative survival and model the effects of prognostic factors in cancer survival studies. Stat Med 2007;26:2214-18.
19. White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. Stat Med 2011;30:377-99.
20. Demeter SJ, Chmielowiec C, Logus W, et al. The descriptive epidemiology of primary lung cancer in an Alberta cohort with a multivariate analysis of survival to two years. Can Respir J 2003;10:435-41. (Pubitemid 38195708)
21. Brooks DR, Klint A, Dickman PW, et al. Temporal trends in non-small cell lung cancer survival in Sweden. Br J Cancer 2007;96:519-22. (Pubitemid 46215227)
22. Holmberg L, Sandin F, Bray F, et al. National comparisons of lung cancer survival in England, Norway and Sweden 2001-2004: differences occur early in follow-up. Thorax 2010;65:436-41.
23. Lungcancer i Sverige: Nationellt register för lungcancer. Regionala jämförelser 2002-2008. http://www.vinkcancer.se/Global/Diagnoser/ lungcancer/rapporter/NLCR-rapport-02-08-reg-jamforelser.pdf (accessed 20 Feb. 2012).
24. Beckett P, Woolhouse I, Peake MD, et al. The influence of age on management of lung cancer patients in England (abstract). Thorax 2010;65:167-8.
25. Erridge SC, Møller H, Price A, et al. International comparisons of survival from lung cancer: pitfalls and warnings. Nat Clin Pract Oncol 2007;4:570-7. (Pubitemid 47534756)
26. Micheli A, Ciampichini R, Oberaigner W, et al. The advantage of women in cancer survival: an analysis of EUROCARE-4 data. Eur J Cancer 2009;45:1017-27.
27. Barlow L, Westergren K, Holmberg L, et al. The completeness of the Swedish Cancer Register-a sample survey for year 1998. Acta Oncol 2009;48:27-33.
28. World Health Organisation. WHO Report on the Global Tobacco Epidemic. Geneva, Switzerland: 2008.
29. Olesen F, Hansen RP, Vedsted P. Delay in diagnosis: the experience in Denmark. Br J Cancer 2009;101(Suppl 2):5-8.
30. Richards MA. The National Awareness and Early Diagnosis Initiative in England: assembling the evidence. Br J Cancer 2009;101(Suppl 2):1-4.
31. National Cancer Intelligence Network. Major surgical resections England, 2004-2006. London, UK: National Cancer Intelligence Network, 2011.
32. NHS Information Centre (NHSIC). National Lung Cancer Audit 2010. Report No: IC03020211. Leeds: NHSIC, 2011.
33. Imperatori A, Harrison RN, Leitch DN, et al. Lung cancer in Teesside (UK) and Vares (Italy): a comparison of management and survival. Thorax 2006;61:232-9.
34. Myrdal G, Lamberg K, Lambe M, et al. Regional differences in treatment and outcome in non-small cell lung cancer: a population-based study (Sweden). Lung Cancer 2009;63:16-22.
35. Erridge SC, Murray B, Williams L, et al. Improved survival from lung cancer in British Columbia compared to Scotland-are different treatment rates the whole story? Lung Cancer 2009;64:358-66.
36. Vinod SK, Sidhom MA, Gabriel GS, et al. Why do some lung cancer patients receive no anticancer treatment? J Thorac Oncol 2010;5:1025-32.